Global Cosmetic Surgery and Procedures Market Overview to 2030

0

company logo

Global cosmetic surgery and procedures market

Global cosmetic surgery and procedures market

Global cosmetic surgery and procedures market

Dublin, June 03, 2022 (GLOBE NEWSWIRE) — The “Aesthetic Surgery and Procedures Market Size, Share, and Trend Analysis Report by Type (Invasive, Non-Invasive), Region (North America, Asia-Pacific, Middle East & Africa, Americas Latin America, Europe) and Segment Forecast, 2022-2030” report has been added to from ResearchAndMarkets.com offer.

The global cosmetic surgery and procedures market size is expected to reach USD 145.7 billion by 2030, registering a CAGR of 9.6%. Technological developments, growing use of social media, and increasing disposable income are some of the factors that are likely to drive the market during the forecast period.

The substantial increase in the volume of cosmetic procedures can be attributed to the popularity of digital photography, growing consumer demand for boosting self-esteem, introduction of self-monitoring apps, and increasing affordability cosmetic surgeries in developing countries. Additionally, the risk associated with cosmetic surgery has decreased due to technological developments and the presence of skilled surgeons.

It has been observed that the volume of surgical and non-surgical cosmetic procedures has increased over the past few years. This can be attributed to increasing disposable income, increasing safety of surgical procedures, increasing patient confidence in these surgeries, and growing medical tourism.

Highlights of the Cosmetic Surgery and Procedures Market Report

  • The increase in the volume of cosmetic surgeries due to the growing demand from emerging countries is expected to boost the market.

  • The cosmetic surgery or surgical procedure segment accounted for the maximum share in 2016 owing to the growing accessibility of cosmetic procedures, increasing safety of surgeries, increasing reliance of patients on surgeries to obtain positive results, the presence of qualified surgeons and the long duration. results.

  • The non-surgical cosmetic procedures segment is expected to witness the fastest growth in the coming years due to higher awareness and lower risk compared to surgical procedures. Moreover, non-surgical procedures are more economical and a large number of relevant service providers are readily available.

  • Geographically, North America dominated the cosmetic surgery and procedures market in 2016. It is expected to maintain its dominance over the forecast period due to increased awareness of cosmetic procedures, higher healthcare expenditure compared to other developing countries and greater adoption of the procedures by both women and men.

  • The cosmetic surgery and procedures industry in Asia Pacific is expected to experience the fastest growth over the next decade owing to the growth in medical tourism, improved healthcare infrastructure and availability of services. High quality.

  • People from developed countries travel to India, Brazil, Mexico, Malaysia and South Korea for affordable cosmetic procedures. Hence, the market is expected to witness high growth in developing countries.

  • Some of the key players operating in the market are ALLERGAN; Merz Pharma; Nestle; Cutera; Cynosure, Inc.; Ipsen; Sientra, Inc.; Alma Lasers; and Johnson & Johnson.

Main topics covered:

Chapter 1. Methodology and scope

Chapter 2. Executive Summary

Chapter 3. Cosmetic Surgery and Procedures Market Variables, Trends and Scope
3.1. Market Line Prospects
3.1.1. Parent Market Outlook
3.2. Mapping of penetration and growth prospects
3.3. Market dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Increase in the adoption of minimally invasive treatments
3.3.1.2. Growing population aged 25-65
3.3.2. Market Restriction Analysis
3.3.2.1. Lack of reimbursement coverage
3.3.2.2. Rigorous regulatory framework
3.4. Cosmetic surgery and procedure: market analysis tools
3.4.1. Industry Analysis – Porter’s
3.4.2. PESTEL analysis
3.4.3. Analysis of major transactions and strategic alliances

Chapter 4. Cosmetic Surgery and Procedures Market: Segment Analysis, by Procedure Type, 2018-2030 (USD Million)
4.1. Definitions and scope
4.2. Procedural Type Market Share Analysis, 2021 & 2030
4.3. Global cosmetic surgery and procedures market, by type of procedure, 2017 to 2030
4.4. Market size and forecast and trend analysis, 2017 to 2030 for the following
4.4.1. Invasive procedures
4.4.1.1. Mammal augmentation
4.4.1.2. Liposuction
4.4.1.3. Nose reshaping
4.4.1.4. Eyelid surgery
4.4.1.5. Abdominoplasty
4.4.1.6. Others
4.4.2. Non-invasive procedure
4.4.2.1. Botox injections
4.4.2.2. Soft tissue fillers
4.4.2.3. Chemical peel
4.4.2.4. Laser hair removal
4.4.2.5. Microdermabrasion
4.4.2.6. Others

Chapter 5. Cosmetic Surgery and Procedures Market: Regional Market Analysis, by Region, 2018-2030 (USD Million)

Chapter 6. Competitive Analysis of Cosmetic Surgery and Procedures Market
6.1. Company/Competitor Categorization (Key Innovators, Market Leaders, Emerging Players)
6.2. Supplier Landscape
6.2.1. List of major distributors and distribution partners
6.3. Profiled Key Companies
6.3.1. Evolves, Inc.
6.3.1.1. Company presentation
6.3.1.2. Financial performance
6.3.1.3. Product Benchmarking
6.3.1.4. Strategic initiatives
6.3.2. Point of focus.
6.3.2.1. Company presentation
6.3.2.2. Financial performance
6.3.2.3. Product Benchmarking
6.3.2.4. Strategic initiatives
6.3.3. Revance Therapeutics, Inc.
6.3.3.1. Company presentation
6.3.3.2. Financial performance
6.3.3.3. Product Benchmarking
6.3.3.4. Strategic initiatives
6.3.4. Galderma SA
6.3.4.1. Company presentation
6.3.4.2. Financial performance
6.3.4.3. Product Benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Alma’s Lasers
6.3.5.1. Company presentation
6.3.5.2. Financial performance
6.3.5.3. Product Benchmarking
6.3.5.4. Strategic initiatives
6.3.6. AbbVie
6.3.6.1. Company presentation
6.3.6.2. Financial performance
6.3.6.3. Product Benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Solta Medical
6.3.7.1. Company presentation
6.3.7.2. Financial performance
6.3.7.3. Product Benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Lumenis
6.3.8.1. Company presentation
6.3.8.2. Financial performance
6.3.8.3. Product Benchmarking
6.3.8.4. Strategic initiatives
6.3.9. Syneron Candela
6.3.9.1. Company presentation
6.3.9.2. Financial performance
6.3.9.3. Product Benchmarking
6.3.9.4. Strategic initiatives

For more information on this report, visit https://www.researchandmarkets.com/r/4flz9n

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Share.

Comments are closed.